Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. PBA
3. ALAR
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SPY
10. SKA-B

Go back to Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts
(NASDAQ: CMND) Delayed: 2.36 +0.06 (2.61%)
Previous Close $2.30    52 Week High $ 
Open $2.28    52 Week Low $ 
Day High $2.42    P/E N/A 
Day Low $2.28    EPS $ 
Volume 66,623